在过敏性鼻炎患者中增加了2型炎症反应,这些患者经历了对家尘虫的全身反应 皮下免疫治疗
概括
过敏性鼻炎患者在室内灰尘子皮下免疫疗法期间出现全身反应,表现出增强的2型炎症反应. 然而,SCIT在低剂量过敏原提取物时仍然有效.
科学领域:
- 免疫学 免疫学 免疫学
- 过敏学 过敏学
- 呼吸系统医学 呼吸系统医学
背景情况:
- 对过敏性鼻炎 (AR) 的皮下免疫疗法 (SCIT) 可以引起全身反应 (SRs).
- 在SCIT期间驱动SRs的精确机制尚未完全理解.
- 了解这些机制对于优化AR治疗至关重要.
研究的目的:
- 调查在HDM SCIT期间经历SR的AR患者的免疫和临床特征.
- 将这些特征与没有SR的对照组进行比较.
- 评估SCIT在SRs患者中的有效性.
主要方法:
- 接受标准化HDM SCIT的AR患者进行了查.
- 研究组:两个连续SRs的患者;控制组:没有SRs的匹配患者.
- 在SCIT之前和一年后分析了临床和免疫学参数.
主要成果:
- 研究小组的AR发病率较高,喘和高特异性IgE增加到HDM.
- 在研究小组中观察到较高的血清IL-4和IL-13水平.
- 尽管由于SRs的维持剂量较低,但SCIT在一年后在两组中改善了VAS得分和肺功能.
结论:
- 增强的2型炎症是HDM诱导的AR患者在SCIT期间经历SR的特征.
- 在这些患者中,SCIT是有效的,即使降低了过敏原提取物剂量.
- 这表明需要针对敏感个体量身定制的免疫疗法方法.
相关概念视频
Allergic Reactions
27.3K
Overview
27.3K
Hypersensitivities
569
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
569
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Allergic Drug Reactions
827
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
827
Asthma: Pathogenesis and Management
379
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
379
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
264
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
264


